-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reiterates Outperform on Ardent Health Partners, Maintains $23 Price Target

Benzinga·11/14/2024 16:48:49
Listen to the news
RBC Capital analyst Ben Hendrix reiterates Ardent Health Partners (NYSE:ARDT) with a Outperform and maintains $23 price target.